ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $87,000 | -92.8% | 1,536 | -94.4% | 0.00% | -90.5% |
| Q2 2021 | $1,212,000 | +46.7% | 27,536 | +64.4% | 0.02% | +50.0% |
| Q1 2021 | $826,000 | +184.8% | 16,746 | +142.7% | 0.01% | +180.0% |
| Q4 2020 | $290,000 | -8.2% | 6,900 | 0.0% | 0.01% | -28.6% |
| Q3 2020 | $316,000 | -8.7% | 6,900 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $346,000 | -2.5% | 6,900 | 0.0% | 0.01% | -20.0% |
| Q1 2020 | $355,000 | -16.7% | 6,900 | 0.0% | 0.01% | +11.1% |
| Q4 2019 | $426,000 | -19.5% | 6,900 | -21.6% | 0.01% | -10.0% |
| Q3 2019 | $529,000 | +677.9% | 8,800 | +1000.0% | 0.01% | +900.0% |
| Q2 2019 | $68,000 | -10.5% | 800 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $76,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
| Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
| Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
| Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
| Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
| Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |